BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Clostridium butyricum MIYAIRI 588 {Miyarisan} - unclassified Escherichia |
👶
[Research cited on Manufacture Website]. Research cited on Manufacture Website (WebSite ) Vol: 0 Issue 0 Pages: 0 Pub: 2018 Jan Epub: Authors Miyarisan Labs , |
| Clostridium butyricum MIYAIRI 588 {Miyarisan} - unclassified Escherichia |
👶
[Antagonistic interaction between Clostridium butyricum and enterohemorrhagic Escherichia coli O157:H7]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases (Kansenshogaku Zasshi ) Vol: 73 Issue 1 Pages: 7-14 Pub: 1999 Jan Epub: Authors Takahashi M , Taguchi H , Yamaguchi H , Osaki T , Sakazaki R , Kamiya S , Publication Publication |
| Clostridium butyricum MIYAIRI 588 {Miyarisan} - unclassified Escherichia |
👶
Effects of Clostridium butyricum on growth performance, immune function, and cecal microflora in broiler chickens challenged with Escherichia coli K88. Poultry science (Poult Sci ) Vol: 93 Issue 1 Pages: 46-53 Pub: 2014 Jan Epub: Authors Zhang L , Cao GT , Zeng XF , Zhou L , Ferket PR , Xiao YP , Chen AG , Yang CM , Publication Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
